Is Ativan (lorazepam) a suitable treatment for rumination?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Ativan (lorazepam) is not a suitable treatment for rumination disorder due to its potential for dependence, tolerance, sedation, and cognitive impairment, and its inability to address the core behavioral mechanisms of rumination. Rumination, which involves repetitive regurgitation of food after eating, is primarily treated through behavioral techniques rather than medication. Cognitive behavioral therapy (CBT), diaphragmatic breathing, and habit reversal training are more appropriate initial approaches 1. While Ativan, a benzodiazepine, can reduce anxiety that might accompany rumination, its use is not recommended due to the significant risks associated with its use, particularly in the long term 1.

Some key points to consider when evaluating the use of Ativan for rumination include:

  • The potential for dependence and tolerance, which can lead to increased dosages and worsening of symptoms 1
  • The risk of sedation and cognitive impairment, which can impact daily functioning and quality of life 1
  • The lack of evidence supporting the use of benzodiazepines in addressing the core behavioral mechanisms of rumination 1
  • The availability of alternative treatments, such as CBT and habit reversal training, which have been shown to be effective in managing rumination symptoms 1

If medication is needed, options like low-dose SSRIs might be considered for anxiety components, but only as part of a comprehensive treatment plan that includes behavioral therapy 1. Any medication approach should be discussed with a healthcare provider who can evaluate individual circumstances and monitor for side effects.

From the Research

Treatment Options for Rumination

  • Rumination syndrome is a functional gastrointestinal disorder characterized by effortless postprandial regurgitation, often accompanied by anxiety and psychological stress 2, 3, 4.
  • The main therapy for rumination syndrome is behavioral modification with postprandial diaphragmatic breathing 3, 4.
  • Other treatment options include tricyclic antidepressants (TCAs) combined with diaphragmatic breathing/relaxation techniques, which have been shown to be effective in managing rumination syndrome 2.
  • Baclofen is also considered a reasonable next step in refractory patients 3.

Use of Benzodiazepines

  • Benzodiazepines, such as Ativan (lorazepam), are not specifically mentioned as a treatment for rumination syndrome in the provided studies 2, 3, 4.
  • However, benzodiazepines are used to treat anxiety, which is often an accompanying complaint in patients with rumination syndrome 5.
  • The use of benzodiazepines should be considered carefully, as they can have adverse effects, such as psychomotor impairment, and can lead to tolerance, dependence, and withdrawal effects with long-term use 5.

Alternative Treatments

  • Mindfulness-based and cognitive behavioral interventions have been shown to be effective in reducing rumination and worry, which are key components of mental illnesses such as depression and anxiety 6.
  • These interventions may be useful in reducing the incidence of rumination and worry, and could be considered as alternative or adjunctive treatments for rumination syndrome.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diagnosis and Treatment of Rumination Syndrome.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2018

Research

Diagnosis and Treatment of Rumination Syndrome: A Critical Review.

The American journal of gastroenterology, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.